喉部炎性肌成纤维细胞瘤1例报告。

IF 1 4区医学 Q3 OTORHINOLARYNGOLOGY Ent-Ear Nose & Throat Journal Pub Date : 2025-02-01 Epub Date: 2022-05-09 DOI:10.1177/01455613221101087

Andrea Colizza, Piero Giuseppe Meliante, Samantha Donsante, Mara Riminucci, Antonio Greco, Marco De Vincentiis, Alessandro Corsi

{"title":"喉部炎性肌成纤维细胞瘤1例报告。","authors":"Andrea Colizza, Piero Giuseppe Meliante, Samantha Donsante, Mara Riminucci, Antonio Greco, Marco De Vincentiis, Alessandro Corsi","doi":"10.1177/01455613221101087","DOIUrl":null,"url":null,"abstract":"Only 0.3-1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment.We report a case of ALK-1-negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.","PeriodicalId":51041,"journal":{"name":"Ent-Ear Nose & Throat Journal","volume":"1 1","pages":"NP68-NP71"},"PeriodicalIF":1.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inflammatory myofibroblastic tumour of the larynx: report of a case.\",\"authors\":\"Andrea Colizza, Piero Giuseppe Meliante, Samantha Donsante, Mara Riminucci, Antonio Greco, Marco De Vincentiis, Alessandro Corsi\",\"doi\":\"10.1177/01455613221101087\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Only 0.3-1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment.We report a case of ALK-1-negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.\",\"PeriodicalId\":51041,\"journal\":{\"name\":\"Ent-Ear Nose & Throat Journal\",\"volume\":\"1 1\",\"pages\":\"NP68-NP71\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ent-Ear Nose & Throat Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/01455613221101087\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ent-Ear Nose & Throat Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/01455613221101087","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

只有0.3-1%的癌症是非鳞状细胞肿瘤。其中，一种罕见的实体是炎性肌成纤维细胞瘤（IMT），其中间变性淋巴瘤激酶-1（ALK-1）经常表达。目前仅报告了50例IMT病例。因此，许多耳鼻喉科医生可能不熟悉这种类型的肿瘤，并且容易对其治疗过度或不足。我们报告了一例ALK-1阴性IMT患者，经口内镜切除，术后6个月无病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Inflammatory myofibroblastic tumour of the larynx: report of a case.

Only 0.3-1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment.We report a case of ALK-1-negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Ent-Ear Nose & Throat Journal 医学-耳鼻喉科学

CiteScore

3.20

自引率

0.00%

发文量

385

审稿时长

6-12 weeks

期刊介绍： Ear, Nose & Throat Journal provides practical, peer-reviewed original clinical articles, highlighting scientific research relevant to clinical care, and case reports that describe unusual entities or innovative approaches to treatment and case management. ENT Journal utilizes multiple channels to deliver authoritative and timely content that informs, engages, and shapes the industry now and into the future.